Roleda, Grace M.

HRN: 18-39-35  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2022
CEFTRIAXONE 1G (VIAL)
11/11/2022
11/17/2022
IVT
2gms
Od
Acute Cystitis
Waiting Final Action 
11/13/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/13/2022
11/13/2022
IV
4.5gms
Now
Hospital Acquired Pneumonia
Waiting Final Action 
11/13/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/13/2022
11/19/2022
IV
2.25gms
Q8
Hospital Acquired Pneumonia
Waiting Final Action 
11/13/2022
LEVOFLOXACIN 500MG (TAB)
11/13/2022
11/19/2022
PO
500mg
Od
Hospital Acquired Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: